<ARTICLE>      5
 <LEGEND>
                This schedule contains summary information
                extracted from the Statements of Operations and
                Balance Sheets of InVitro International and is
                qualified in its entirety by reference to such    
                financial statements.
 </LEGEND>
 <CIK>          0000872610
 <NAME>         INVITRO INTERNATIONAL
 <MULTIPLIER>   1000
                                             
 <FISCAL-YEAR-END>                     Sep-30-1997 
 <PERIOD-START>                        Oct-01-1996 
 <PERIOD-END>  Dec-31-1996 
 <PERIOD-TYPE> 3-MOS 
 <CASH>          859 
 <SECURITIES>                                    0 
 <RECEIVABLES>                                 203 
 <ALLOWANCES>                                   15 
 <INVENTORY>                                   510 
 <CURRENT-ASSETS>                            1,594 
 <PP&E>                                      1,049 
 <DEPRECIATION>                                846 
 <TOTAL-ASSETS>                              1,954 
 <CURRENT-LIABILITIES>                         399 
 <BONDS>                                         0 
 <PREFERRED-MANDATORY>                           0 
 <PREFERRED>                                     0 
 <COMMON>                                   25,036 
 <OTHER-SE>                                (23,481)
 <TOTAL-LIABILITY-AND-EQUITY>                1,954 
 <SALES>                                       259 
 <TOTAL-REVENUES>                              259 
 <CGS>                                         184 
 <TOTAL-COSTS>                                 779 
 <OTHER-EXPENSES>                              (14)
 <LOSS-PROVISION>                                0 
 <INTEREST-EXPENSE>                              0 
 <INCOME-PRETAX>                              (506)
 <INCOME-TAX>                                    0 
 <INCOME-CONTINUING>                          (506)
 <DISCONTINUED>                                  0 
 <EXTRAORDINARY>                                 0 
 <CHANGES>                                       0 
 <NET-INCOME>                                 (506)
 <EPS-PRIMARY>                                (.04)
 <EPS-DILUTED>                                (.04)